SWOG clinical trial number
CTSU/A021806
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Open
Abbreviated Title
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Status Notes
This study is active in SWOG as of July 1, 2020.
Activated
07/01/2020
Research committees
Gastrointestinal Cancer
Eligibility Criteria Expand/Collapse
Please see eligibility criteria in protocol on www.CTSU.org
Other Clinical Trials
SWOG Clinical Trial Number
S2001
Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects
Research Committee(s)
Gastrointestinal Cancer
Activated
12/04/2020
Accrual
0%
Open
Phase
II
SWOG Clinical Trial Number
CTSU/A021806
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
07/01/2020
Open
SWOG Clinical Trial Number
S1922
Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
12/16/2019
Accrual
9%
Open
Phase
II